Literature DB >> 6620188

The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.

W Knepel, D K Meyer.   

Abstract

Rat posterior pituitaries were superfused in vitro and stimulated electrically. The concentrations of vasopressin in the superfusion medium were determined by radioimmunoassay. When the pulses were applied in 10 sec trains with 10 sec intervals, vasopressin release per pulse increased progressively over the frequency range of 3-12 pulses/sec applied within the trains. The release was blocked by addition of tetrodotoxin or by removal of calcium ions from the superfusion medium. The opiate antagonist naloxone 1 or 10 microM was introduced into the superfusion medium before a second period of stimulation and enhanced vasopressin release from neurointermediate lobes after phasic stimulation at 9 pulses/sec within the trains, when compared to controls. However, naloxone 10 microM had not effect on vasopressin release from isolated neural lobes (intermediate lobes removed), although the addition of camel beta-endorphin 2 microM inhibited vasopressin release in a naloxone-reversible manner. After continuous stimulation at a frequency of 13 Hz naloxone 10 microM did not influence the release of vasopressin from neurointermediate lobes. We conclude that the evoked release of vasopressin from the neurointermediate lobe is reduced by an endogenous opiate of intermediate lobe origin, possibly beta-endorphin. Appropriate stimulation conditions are necessary for this mechanism to function.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6620188      PMCID: PMC1195347          DOI: 10.1113/jphysiol.1983.sp014820

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  39 in total

1.  Opiate receptor binding in the pituitary gland.

Authors:  R Simantov; S H Snyder
Journal:  Brain Res       Date:  1977-03-18       Impact factor: 3.252

2.  Hypothalamic-pituitary vasculature: evidence for retrograde blood flow in the pituitary stalk.

Authors:  C Oliver; R S Mical; J C Porter
Journal:  Endocrinology       Date:  1977-08       Impact factor: 4.736

3.  Hypothalamic enkephalin neurones may regulate the neurohypophysis.

Authors:  J Rossier; E Battenberg; Q Pittman; A Bayon; L Koda; R Miller; R Guillemin; F Bloom
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

4.  Biogenic amines and control of melanophore stimulating hormone release.

Authors:  A Bower; M E Hadley; V J Hruby
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

5.  Release of vasopressin by enkephalin.

Authors:  G W Bisset; H S Chowdrey; W Feldberg
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

6.  Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro.

Authors:  K Starke; W Reimann; A Zumstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

7.  Can the pituitary secrete directly to the brain? (Affirmative anatomical evidence).

Authors:  R M Bergland; R B Page
Journal:  Endocrinology       Date:  1978-05       Impact factor: 4.736

8.  Comparison of firing patterns in oxytocin- and vasopressin-releasing neurones during progressive dehydration.

Authors:  J B Wakerley; D A Poulain; D Brown
Journal:  Brain Res       Date:  1978-06-16       Impact factor: 3.252

9.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.

Authors:  R Guillemin; T Vargo; J Rossier; S Minick; N Ling; C Rivier; W Vale; F Bloom
Journal:  Science       Date:  1977-09-30       Impact factor: 47.728

10.  Effects of veratridine on Ca fluxes and the release of oxytocin and vasopressin from the isolated rat neurohypophysis.

Authors:  J J Nordmann; R E Dyball
Journal:  J Gen Physiol       Date:  1978-09       Impact factor: 4.086

View more
  8 in total

1.  Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells.

Authors:  N R Smalheiser; E Costa; A Guidotti; F Impagnatiello; J Auta; P Lacor; V Kriho; G D Pappas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Naloxone excites oxytocin neurones in the supraoptic nucleus of lactating rats after chronic morphine treatment.

Authors:  R J Bicknell; G Leng; D W Lincoln; J A Russell
Journal:  J Physiol       Date:  1988-02       Impact factor: 5.182

3.  Neurohypophysial opioids and oxytocin secretion: source of inhibitory opioids.

Authors:  R J Bicknell; C Chapman; G Leng
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

Review 4.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

5.  Intracellular calcium and hormone release from nerve endings of the neurohypophysis in the presence of opioid agonists and antagonists.

Authors:  G Dayanithi; E L Stuenkel; J J Nordmann
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

6.  Do opioid peptides modulate, at the level of the nerve endings, the release of neurohypophysial hormones?

Authors:  J J Nordmann; G Dayanithi; M Cazalis
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

7.  Opiate binding differentially associated with oxytocin and vasopressin nerve endings from porcine neurohypophyses.

Authors:  N Falke; R Martin
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

8.  Modulation by fenoldopam (SKF 82526) and bromocriptine of the electrically evoked release of vasopressin from the rat neurohypophysis. Effects of dopamine depletion.

Authors:  K Racké; J Meuresch; B Trapp; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.